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Abstract
Objectives
Omega (ω)-3 polyunsaturated fatty acids (PUFA) are dietary compounds able to attenuate
insulin resistance. Anyway, the precise actions ofω-3PUFAs in skeletal muscle are over-
looked. We hypothesized that PUFAs, modulating mitochondrial function and efficiency,
would ameliorate pro-inflammatory and pro-oxidant signs of nutritionally induced obesity.
Study Design
To this aim, rats were fed a control diet (CD) or isocaloric high fat diets containing eitherω-3
PUFA (FD) or lard (LD) for 6 weeks.
Results
FD rats showed lower weight, lipid gain and energy efficiency compared to LD-fed animals,
showing higher energy expenditure and O2 consumption/CO2 production. Serum lipid pro-
file and pro-inflammatory parameters in FD-fed animals were reduced compared to LD.
Accordingly, FD rats exhibited a higher glucose tolerance revealed by an improved glucose
and insulin tolerance tests compared to LD, accompanied by a restoration of insulin signal-
ling in skeletal muscle. PUFAs increased lipid oxidation and reduced energy efficiency in
subsarcolemmal mitochondria, and increase AMPK activation, reducing both endoplasmic
reticulum and oxidative stress. Increased mitochondrial respiration was related to an
increased mitochondriogenesis in FD skeletal muscle, as shown by the increase in PGC1-α
and -β.
PLOS ONE | DOI:10.1371/journal.pone.0149033 February 22, 2016 1 / 19
OPEN ACCESS
Citation: Cavaliere G, Trinchese G, Bergamo P, De
Filippo C, Mattace Raso G, Gifuni G, et al. (2016)
Polyunsaturated Fatty Acids Attenuate Diet Induced
Obesity and Insulin Resistance, Modulating
Mitochondrial Respiratory Uncoupling in Rat Skeletal
Muscle. PLoS ONE 11(2): e0149033. doi:10.1371/
journal.pone.0149033
Editor: Zane Andrews, Monash University,
AUSTRALIA
Received: July 2, 2015
Accepted: January 26, 2016
Published: February 22, 2016
Copyright: © 2016 Cavaliere et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This work was supported by the University
of Naples Federico II, grant number COAN
CA0440050101. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Conclusions
our data strengthened the association of high dietaryω3-PUFA intake with reduced mito-
chondrial energy efficiency in the skeletal muscle.
Introduction
When food intake chronically exceeds metabolic needs, efficient metabolism causes continued
energy storage and results in obesity, a common condition associated with diabetes, hyperlipid-
emia and inflammatory state.
Although the peripheral insulin resistance is still not fully understood, several mechanisms
have been proposed, including an increase of intracellular lipid metabolites, inflammation,
endoplasmic reticulum (ER) stress and mitochondrial dysfunction [1–3]. In particular, ER
stress appears to act directly as a negative modulator of insulin signalling, and indirectly pro-
moting lipid accumulation [4,5]. Activation of AMP-activated protein kinase (AMPK) protects
against lipid-induced hepatic [6] and skeletal muscle disorders, reducing ER stress [7].
The beneficial effects of adiponectin, including anti-inflammatory and insulin-sensitizing
actions, have been well established [8–10]. Adiponectin plays an important role in the patho-
physiology of diabetes in obesity, at least in part via regulating metabolism in skeletal muscle
[9]. Adiponectin, as well as leptin, directly modulate fatty acid metabolism in skeletal muscle
by increasing fatty acid oxidation and suppressing fatty acid synthesis via mechanisms involv-
ing AMPK activation [11,12]. Adiponectin also confers beneficial metabolic effects in muscle
by enhancing mitochondrial biogenesis [13].
Mitochondria are at the centre of glucose and fatty acid metabolism. In fact, mitochondrial
dysfunction, increased production of reactive oxygen species (ROS), and impaired mitochon-
drial biogenesis are considered the key determinants of insulin resistance and obesity [2,3].
Mitochondrial uncoupling, which reduces the proton gradient across the mitochondrial
inner membrane, creates a futile cycle of glucose and fatty acid oxidation without generating
ATP [14–17], increasing lipid oxidation and reducing intracellular lipid content [18,19]. Pro-
moting inefficient metabolism, such as the generation of heat instead of ATP, is a potential
treatment for obesity. In fact, the modulation of mitochondrial function and efficiency has
been suggested for the prevention/treatment of obesity and insulin resistance [20]; therefore,
drugs or natural molecules modulating the mitochondrial function and efficiency may be use-
ful in the treatment/prevention of obesity and insulin resistance.
The ω-3 polyunsaturated fatty acids (PUFA), docosahexaenoic acid (DHA) and eicosapen-
taenoic acid (EPA), are dietary compounds that are intensively studied as potent anti-inflam-
matory products, able to reduce the risk of insulin resistance and ameliorate obesity-associated
disorders through affecting hormonal control and modulating AMPK activity [21, 22].
Recently, we have demonstrated that the replacement of lard, rich in saturated fatty acids
(SFA), with fish oil (rich in ω-3 PUFA) in high-fat diet is able to limit the development of sys-
temic and tissue inflammation [23]. In addition, the reduction of hepatic lipid accumulation by
PUFAs resulted by an improved mitochondrial fatty acid utilization associated with mitochon-
drial mild uncoupling, which counteracted the hepatocyte damage induced by long-term over-
feeding [24].
Skeletal muscle, the main site of insulin-mediated glucose disposal and triglyceride clear-
ance, is another attractive site for altering metabolism and adiposity, through engineered respi-
ratory uncoupling. In fact, skeletal muscle is a chief determinant of resting metabolic rate,
whose reduction is associated with weight gain [25].
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Here, we hypothesized that the ω-3 PUFAs, showing an increased ability to modulate mito-
chondrial function and efficiency, would also ameliorate pro-inflammatory and pro-oxidant
signs of fat overnutrition. To test this hypothesis, rats were fed a control diet (CD) or high fat iso-
caloric diets containing either ω-3 PUFA (FD) or lard (LD) for 6 weeks. We focused on mito-
chondrial function, efficiency and biogenesis of mitochondria located beneath the sarcolemmal
membrane (subsarcolemmal [SS]) or between the myofibrils (intermyofibrillar [IMF]) in skeletal
muscle. In fact, these two mitochondrial populations exhibit different energetic characteristics
[26,27] and therefore can be differently affected by physio-pathological stimuli. Finally, cytopro-
tective enzymes activities and ER stress modulation by ω-3 PUFAs were analyzed.
Materials and Methods
Ethics statement
Procedures involving animals and their care were conducted in conformity with international
and national law and policies (EU Directive 2010/63/EU for animal experiments, ARRIVE
guidelines and the Basel declaration including the 3R concept). The procedures reported here
were approved by the Institutional Committee on the Ethics of Animal Experiments (CSV) of
the University of Naples “Federico II” and by the Ministero della Salute.
Experimental procedures
All chemicals were purchased by Sigma–Aldrich (St. Louis, MO, USA), unless otherwise speci-
fied. Young male Wistar rats (60 days old; 345 ± 7 g; Charles River, Calco, Lecco, Italy) were indi-
vidually caged in a temperature-controlled room and exposed to a daily 12h–12h light–dark
cycle with free access to chow diet and drinking water. Rats were divided into 3 experimental
groups (n = 8) according to a different 6 weeks dietary regimen: the first group (control diet, CD)
received a standard diet (10.6%fat J/J); the second group (LD) received the high fat diet rich in
lard (40% fat J/J); the third group (FD) received the high fat diet rich in fish oil (40% fat J/J). The
composition of all dietary regimens is reported in Tables 1–2. An additional group (n = 8) was
sacrificed at the beginning of the study to establish baseline measurements of body compositions.
After 6 weeks feeding, the animals were anaesthetised by injection of chloral hydrate (40
mg/100 g body weight, i.p.), and blood was taken from both the inferior cava and portal vein.
Skeletal muscle was removed; samples not immediately used for mitochondrial preparation
were frozen and stored at -80°C.
Evaluation of body composition and energy balance
During the experimental time, the body weight and food intake were monitored daily to calcu-
late weight gain and gross energy intake. Spilled food and faeces were collected daily for precise
food intake calculation. Energy balance assessments were conducted over the 6 weeks of feed-
ing by the comparative carcass evaluation [28]. The gross energy density for the standard diet
or high fat diets (15.8 or 20.0 kJ/g, respectively), as well as the energy density of the faeces and
the carcasses, were determined by bomb calorimetric (Parr adiabatic calorimetric, Parr Instru-
ment Co., Moline, IL, USA). Energy, fat and protein content in animal carcasses were mea-
sured, according to Iossa et al. [28]. Metabolizable energy (ME) intake was determined by
subtracting the energy measured in faeces and urine from the gross energy intake, which was
determined from the daily food consumption and gross energy density. Energy efficiency was
calculated as the percentage of body energy retained per ME intake, and energy expenditure
was determined as the difference between ME intake and energy gain.
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Table 2. Fatty acid composition (g/100g fatty acid) of experimental diets.
Fatty acid High lard diet High ﬁsh oil diet
SFA 42,64 17,87
10:00 0,05 0,00
12:00 0,11 0,00
14:00 0,76 2,12
16:00 26,89 9,62
18:00 14,83 2,8
MUFA 34,18 35,16
16:1 1,53 4,94
18:1 31,87 19,63
20:1 0,66 6,24
22:1 0,00 4,35
PUFA 22,94 47,14
18:2 20,57 17,1
18:3 2,4 5,32
18:4 0,00 0,56
20:4 0,00 0,56
20:5- n3 0,00 8,1
22:5- n3 0,00 1,2
22:6- n3 0,00 14,3
MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
doi:10.1371/journal.pone.0149033.t002
Table 1. Diet Composition.
Control
Diet
High Lard Diet (g/100g
diet)
High Fish oil Diet (g/100g
diet)
Standard feed 100 51,3 51,3
Caseina g - 9,25 9,25
Lard g - 21,8 -
Fish oil b g - - 21,8
Sunﬂower oil g - 1,24 1,24
AIN 76 mineral mixc g - 1,46 1,46
AIN 76 Vitamin mixd g - 0,42 0,42
Choline bitartrate - 0,08 0,08
Methionine g - 0,12 0,12
Energy density kJ/g
diet
15,88 20,00 20,00
Protein % 29 29 29
Lipid % 10,6 40 40
Carbohydrate % 60,4 31 31
aPuriﬁed high-nitrogen casein containing 88% protein
bFish oil = Cod liver Oil
cAmerican Institute of Nutrition (1977)
dAmerican Institute of Nutrition (1980).
doi:10.1371/journal.pone.0149033.t001
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Measurement of oxygen consumption (VO2), carbon dioxide production
(VCO2) and respiratory quotient (RQ)
Upon an adaption period to the experimental environment (at least 1 day), VO2 and VCO2,
were recorded by a monitoring system (Panlab s.r.l., Cornella, Barcelona, Spain) composed of a
four-chambered indirect open-circuit calorimeter, designed for continuous and simultaneous
monitoring. VO2 and VCO2 were measured every 15 min (for 3 min) in each chamber for a
total of 6 hours (from 8:00 am to 14:00 pm). The mean VO2, VCO2 and RQ values were calcu-
lated by the “Metabolism H” software [29].
Oral glucose tolerance test, insulin tolerance test, and serum analysis
For the oral glucose tolerance test, overnight fasted rats received oral administration of glucose
(3 g/kg body wt) dissolved in water. For the insulin tolerance test, rats were fasted for 5 h and
then injected intraperitoneally with insulin (homolog rapid-acting, 10 units/kg body wt in ster-
ile saline; Novartis, Basel, Switzerland). Samples of blood were collected before the oral glucose
and insulin tolerance tests and at various times thereafter, and glucose and insulin values were
determined by means of a glucose monitor (BRIO, Ascensia, NY), calibrated for use with rats
and ELISA (Mercodia rat insulin; Mercodia, Uppsala, Sweden), respectively.
Basal fasting values of serum glucose and insulin were used to calculate Homoeostatic
Model Assessment (HOMA) index as (Glucose (mg/dL)  Insulin (mU/L))/405 [30].
Plasma concentrations of triglycerides and cholesterol, and non-esterified fatty acids
(NEFAs) were measured by colorimetric enzymatic method using commercial kits (SGM Italia,
Italy and Randox Laboratories ltd., United Kingdom). Commercially available ELISA kits were
used to determine adiponectin and leptin (B-Bridge International, Mountain View, CA), lipo-
polysaccharide (LPS) (Limus Amebocyte Lysate QCL-1000, Lonza Group Ltd), TNF-α and
monocyte chemoattractant protein (MCP)-1 (Thermo Scientific, Rockford, IL).
Analysis in skeletal muscle and mitochondrial parameters
Hind leg muscles were freed of excess fat and connective tissue, finely minced and washed in a
medium containing 100mM KCl, 50mM TRIS, pH 7.5, 5mMMgCl2, 1mM EDTA, 5mM
EGTA, 0.1% (w/v) fatty acid free bovine serum albumin (BSA). Tissue fragments were homog-
enized with the above medium (1: 8, w/v) in a Potter Elvehjem homogenizer (Heidolph, Kel-
heim, Germany) set at 500 rpm (4 strokes = min) and filtered through sterile gauze.
Homogenate was then centrifuged at 500×g for 10 min and the resulting precipitate was
subsequently used for the preparation of the IMF mitochondria. The supernatant was centri-
fuged at 3000×g for 10 min and the resulting pellet, containing SS mitochondria, was washed
twice and resuspended in suspension medium. The pellet from the 500×g centrifugation was
resuspended in a small amount of homogenisation solution and treated with protease nagarse
(9 U/g tissue) for 5 min. The suspension was then homogenised, filtered through sterile gauze
and centrifuged at 3000×g for 10 min. The resulting supernatant was rapidly discarded and the
pellet was resuspended and centrifuged at 500×g for 10 min. The supernatant containing the
IMF mitochondria was centrifuged at 3000×g for 10 min, the pellet was washed once and resus-
pended in suspension medium. Mitochondrial oxygen consumption and basal/palmitate
induced proton-leaks were evaluated [28]. Oxygen consumption was measured polarographi-
cally with a Clark-type electrode (Yellow Springs Instruments, Yellow Springs, Ohio) in a 3-ml
glass cell, at a temperature of 30°C. Isolated SS or IMF mitochondria (0.1 mg protein/ml) were
incubated in a medium containing 30 mM KCl, 6 mMMgCl2, 75 mM sucrose, 1 mM EDTA,
20 mM KH2PO4 pH 7.0, and 0.1% (w/v) fatty acid-free BSA. In the presence of 10 mM
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succinate, 3.75 mM rotenone and 0.6 mM ADP, state 3 oxygen consumption was measured.
State 4 was obtained in the absence of ADP. The respiratory control ratio (RCR) was calculated
as the ratio between states 3 and 4. In control experiments, we assured the quality of our mito-
chondrial preparation by checking that contamination of mitochondria by other ATPase-con-
taining membranes was lower than 10%, and addition of cytochrome c (3 nmol/mg protein)
only enhanced state 3 respiration by approximately 10%. Measurements of basal proton leak
kinetics was performed as below reported. Mitochondrial oxygen consumption was measured
polarographically, and membrane potential recordings were performed in parallel with safra-
nin O using a Jasco dual-wavelength spectrophotometer (511–533 nm) (28). The absorbance
readings were transferred to millivolt membrane potential using the Nernst equation,ΔC = 61
mV × log([K+]in/[K+]out), and calibration curves made for each preparation as previously
reported (28). Measurements were carried out at 30°C in a medium containing 30 mmol/l LiCl,
6 mmol/l MgCl2, 75 mmol/l sucrose, 1 mmol/l EDTA, 20 mmol/l Tris-P, pH 7.0, and 0.1%
(wt/vol) BSA in the presence of succinate (10 mmol/l), rotenone (3.75 μmol/l), oligomycin
(2 μg/ml), safranin O (83.3 nmol/mg), and nigericin (80 ng/ml). Oxygen consumption and
membrane potential were titrated by sequential additions of malonate up to 5 mmol/l for SS
and 3 mmol/l for IMF mitochondria. Palmitate-induced proton leak kinetics was evaluated as
above in the presence of palmitate (45 μmol/l and 65 μmol/l for SS and IMF mitochondria,
respectively). Carnitine-palmitoyl-transferase (CPT) activity was followed spectrophotometri-
cally as CoA-sH production by the use of 5,5'-dithiobis(nitrobenzoic acid) (DTNB) and as sub-
strate palmitoyl coa 10 μM. The medium consisted of 50 mM KCl, 10 mMHepes (pH 7.4),
0.025% Triton X-100, 0.3 mM DTNB, and 10–100 pg of mitochondrial protein in a final vol-
ume of 1.0 ml. The reaction was followed at 412 nm with spectrophotometer, and enzyme
activity was calculated from an E412 = 13,600/ (M X cm). The temperature was thermostated
to 25°C [31]. Determination of aconitase specific activity was carried out in a medium contain-
ing 30 mM sodium citrate, 0.6 mMMnCl2, 0.2 mM NADP, 50 mM TRIS-HCl pH 7.4, and 2
units of isocitrate dehydrogenase. The formation of NADPH was followed spectrophotometri-
cally (340 nm) at 25°C. The level of aconitase activity measured equals active aconitase (basal
level). Aconitase inhibited by ROS in vivo was reactivated so that total activity could be mea-
sured by incubating mitochondrial extracts in a medium containing 50 mM dithiothreitol, 0.2
mMNa2S, and 0.2 mM ferrous ammonium sulphate [32]. Rate of mitochondrial H2O2 release
was assayed by following the linear increase in fluorescence (ex 312 nm and em 420 nm) due to
the oxidation of homovanillic acid in the presence of horseradish peroxidase [33].
Skeletal muscle lipid content was determined using Folch method [34] and lipid droplets
were assessed in haematoxylin-eosin stained sections. Adipocyte differentiation-related protein
(ADRP) expression in rat gastrocnemius was assessed immunohistochemically and glycogen
staining with periodic acid-Schiff (PAS).
Oxidative stress markers (Carbonylated Proteins, PC and the GSH/GSSG ratio) were mea-
sured in skeletal muscle. PC concentration was spectrophotometrically measured in blood
plasma and tissue samples, and total thiols (GSH+GSSG) in plasma and the GSH and GSSG
concentrations in rat muscles were determined with the dithionitrobenzoic acid (DTNB)-
GSSG reductase recycling assay [35].
NF-E2-related factor 2 (Nrf2) is considered the main mediator of cellular adaptation to
redox stress and its translocation into the nucleus, upon the dissociation from the Kelch-like
ECH-associated protein 1 (Keap1), triggers the transcription of several enzymes involved in
detoxification and chemopreventive mechanisms (glutathione S-transferases, GSTs; NAD(P)
H:quinone oxidoreductase, NQO1; heme oxygenase-1). To investigate the possible involve-
ment of NF-E2-related factor 2 (Nrf2) in the diet-induced stress, cytoplasmic and nuclear
extracts were prepared from rat muscle tissue [35]. The enzymatic activities of GST and
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NADPH quinone oxidoreductase 1 (NQO1) were evaluated spectrophotometrically in cyto-
plasmic extracts [36–38] and the levels of Nrf2 levels in the nucleus were immunodetected by
Western blotting analysis.
For p-Akt detection in skeletal muscle, additional six rats for each group were feed deprived
for 6 h, then were administered insulin (10 U/Kg) and were killed 15 min after insulin injection
for Western blot analysis.
Western blot analysis
Skeletal muscle were homogenized and total protein lysates were subjected to SDS-PAGE.
Blots were probed with p-Akt (Ser473) and Akt (Cell Signalling, MA, USA, diluted 1:1,000 in
blocking buffer) or TNFα, BiP/ glucose regulated protein (GRP)78, p-eukaryotic translation
initiation factor (eIF)2α, t-eIF2α, p-AMPK, t-AMPK (Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Western blot for tubulin or lamin was performed to ensure equal sample loading.
Quantitative real-time PCR analysis
Total RNA was extracted from skeletal muscle using the TRIzol Reagent (Ambion). After
DNase treatment (Ambion), RNA was quantified using a Nanodrop 2000c spectrophotometer
(ThermoScientific) and reverse-transcribed (1 μg) using the Advantage RT-PCR kit (Clontech)
and oligo dT primer.
Universal Probe Library Assay Design Center (https://www.roche-applied-cience.com/sis/
rtpcr/upl/index.jsp?id=UP030000) was used for designing primers. The Real Time-PCR reac-
tions were performed using a 7500 Real-Time PCR System (Applied Biosystems) in the pres-
ence of 1X Power Sybr Green PCRMaster mix (Applied Biosystems) and 0.1 μM of each
primer and 30 ng of cDNA. The thermal protocol was as follows: 2 min at 50°C, 10 min at
95°C, followed by 40 cycles of 15 sec at 95°C and 1 min at 60°C. For all of the genes examined,
the reactions were conducted in technical duplicates. For each well, the evaluation of PCR effi-
ciency and optimal threshold cycle (CT) of the target genes [peroxisome proliferator-activated
receptor γ coactivator (PGC)1α, PGC1β, fibroblast growth factor (FGF)21] and the endoge-
nous control gene (β-actin) were performed using the REAL TIME PCR MINER online tool
[39]. The mean relative expression ratio (rER) of the target genes was calculated using β-actin
as the endogenous control gene and cDNA as the reference sample applying the formula:
rER ¼ ð1 þ E target geneÞDCT target gene=ð1 þ E endogenous controlÞDCT endogenous control [40],
where ΔCTtarget gene is the difference between the CT value of the target gene in the skeletal muscle
of the FD, LD rats and the CT value of the target gene in the skeletal muscle of the control rats,
ΔCTendogenous control is the difference between the CT value of the β-actin gene in skeletal muscle of
the FD, LD rats and the CT value of the β-actin gene in the skeletal muscle of the control rats [40]
Primer sequences used for Real-Time Polymerase Chain Reaction are the following:
β-actin 5’- ATTGCTGACAGGATGCAGAA-3’ and 5’- TAGAGCCACCAATCCACACAG-3’;
FGF21 5’- CACACCGCAGTCCAGAAAG-3’ and 5’- GGCTTTGACACCCAGGATT- 3’.
PGC1-α 5’- AAAGGGCCAAGCAGAGAGA-3’ and 5’- GTAAATCACACGGCGCTCTT-3’
PGC1-β 5’- TTGACAGTGGAGCTTTGTGG-3’ and 5’- GGGCTTATATGGAGGTGTGG-3’
Statistical analysis
All data are presented as means±SEM. Differences among groups were compared by ANOVA
followed by the Newman-Keuls test to correct for multiple comparisons. Differences were con-
sidered statistically significant at p<0.05. All analyses were performed using GraphPad Prism
(GraphPad Software, San Diego, CA).
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Results
Energy balance
As shown in Table 3, LD rats were characterised by a significant increase of body weight and
weight gain, lipid accumulation and body energy levels compared to CD and FD animals; in
addition, LD rats contained significantly lower percentages of water and protein compared to
CD or FD rats. Despite a comparable ME intake, LD rats showed energy efficiency, body weight
gain (expressed in g and kJ), lipid gain and lipid gain/ME intake values significantly higher
than those of FD-fed animals. Decreased lipid accumulation in FD- compared to LD-fed ani-
mals was associated with higher energy expenditure, increased O2 consumption/CO2 produc-
tion and lower energy efficiency. Moreover, LD and FD rats showed a lower respiratory
quotient (RQ) compared to CD rats. Therefore, the low lipid gain and lipid gain/ME intake of
FD animals (vs LD) indicates an improved ability to utilise fat, as a metabolic fuel.
Serummetabolite levels and glucose homeostasis
Blood parameters and hormonal determination are reported in Table 4. Serum metabolic (tri-
glycerides, cholesterol, and insulin), and pro-inflammatory (TNFα, MCP1 and LPS) parame-
ters in LD-fed animals were increased compared to those measured in rats on CD and,
Table 3. Body composition, energy balance, and calorimetric parameters.
CD LD FD
Body weight
Initial body weight, g 349±3,6a 343±4,5 a 344±2,3 a
Final weight, g 486±16.2 a 636±14,0 b 561±12,4 c
Body weight gain, g 137,6±10.0 a 293±12,0 b 217±11 c
Body composition
Water, % 62.5±0.6a 54.8±2.2b 60.3±0.4a
Lipid, % 11.9±0.6a 22.2±1.6b 16.2±0.7c
Protein, % 18.4±0.2 15.7±0.9b 17.2±0.2a
Body Energy kJ/g 9.0±0.2 12.4±0.5b 10.3±0.3c
Energy balance
ME intake, kJ 13442±403a 20333±508b 20306±211b
Body weight gain, kJ 1233±162a 3760±331b 2237±164c
Energy efﬁciency % 9.0±0.5a 18.0±1.1b 11.0±0.8a
Protein gain kJ 468±30a 377±30b 357±16b
Lipid gain kJ 864±134a 3483±422b 1873±162c
Protein gain/ME intake % 3.5±0.5a 1.9±0.5b 1.8±0.1b
Lipid gain/ME intake % 6.4±1.0a 17.1±1.7b 9.2±0.8a
Energy expenditure kJ 12209±450a 16572±280b 18063±224c
Calorimetric parameters
VO2 (ml/min/Kg
0.75bw) 6.6±0.2a 8.6±0.4b 11.8±0.9c
VCO2 (ml/min/Kg
0.75bw) 6.0±0.3a 7.5±0.3b 10.3±0.4c
RQ (VCO2/VO2) 0.91±0.01
a 0.87±0.01b 0.87±0.01b
ME = Metabolizable energy; Energy efﬁciency = ME intake/bw gain; VO2 = oxygen consumption; VCO2 =
carbon dioxide production; RQ = respiratory quotient VCO2 /VO2.
Data are presented as means ± S.E.M. from n = 8 animals/group. Different superscripted letters indicate
statistically signiﬁcant differences (P < 0.05).
doi:10.1371/journal.pone.0149033.t003
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interestingly, no significant difference was shown in the same parameters between FD and CD.
In contrast, NEFA and leptin concentrations were significantly higher after both high fat diet
regimens compared to CD, however values from LD were significantly higher than those of FD
rats. In addition, adiponectin concentration was reduced in LD compared to CD or FD ani-
mals, while glucose level was significantly increased both in LD or FD.
The HOMA-IR index was significantly greater in LD than in CD or FD-fed animals (Fig
1A). Accordingly, FD rats exhibited a higher tolerance to glucose loading than LD rats; in fact,
despite similar glucose levels, FD rats exhibited a significantly lower insulin concentration and
a reduced insulin area under the curve (AUC) than LD rats (Fig 1B and 1C),. Insulin tolerance
test revealed less glucose reduction, following insulin administration, in LD and FD rats com-
pared to control animals (Fig 1D), however rats on ω-3PUFA high fat diet showed an increased
reduction of glucose levels compared to LD, indicating that fat present in the diet (lard or fish
oil) can differently modify glucose metabolism. In fact, even if FD did not improve glicemic
profile HOMA and insulin secretion results in part recovered, suggesting that in high fat diet
the substitution of lard with ω-3PUFA can ameliorate insulin sensitivity.
Data obtained on insulin signal transduction on skeletal muscle support this hypothesis.
We evaluated Akt phosphorylation in skeletal muscle by western blot analysis after in vivo
stimulation with the hormone. Insulin-stimulated Akt phosphorylation was less in LD-fed rats
than in FD or CD-fed animals (Fig 1E). Significantly higher total lipid content in skeletal mus-
cle (Fig 1F) and the widest glycogen-depleted areas in PAS sections were observed in LD-fed
rats (Fig 1G upper panels). LD animals also exhibited a weaker immunostaining signal for
ADRP in the muscle periphery and around adipocytes in connective tissue (Fig 1G lower pan-
els), while it was similar in CD and FD.
Mitochondrial function: oxidative capacity, efficiency, and oxidative
stress
We found that IMF mitochondria from LD or FD-fed rats exhibited a significant lower State 3
respiration rate than control in presence of succinate, as substrate; conversely, State 3 in SS
sub-population of LD-fed rats was less than that of FD- or CD-fed rats (Fig 2A). State 3, in
presence of palmitoyl carnitine, was similar in IMF sub-population of LD and FD-fed animals
and significantly higher than those measured in CD rats (Fig 2B). Conversely, in the same
Table 4. Blood Parameters.
CD LD FD
NEFA (mmol/L) 0.27±0.01a 0.43±0.02b 0.34±0.01c
Triglycerides (mg/dL) 51.6±4.0a 73.2±2.4b 55.0±3.0a
Cholesterol (mg/dL) 47.8±1.1a 72.2±8.7b 47.5±1.2a
Leptin (ng/mL) 10.7±0.9a 19.2±1.2b 14.1±1.2c
Adiponectin (μg/mL) 5.9±0.3a 4.3±0.6b 6.3±0.6a
Glucose (mg/dL) 84.1±2.6a 106.8±5.3b 105.8±7.3b
Insulin (μg/L) 0.6±0.2a 1.2±0.1b 0.6±0.1a
TNFα (ng/ml) 0.11±0.01a 0.21±0.02b 0.13±0.01a
MCP1 (ng/mL) 2.9±0.4a 7.4±0.8b 3.8±0.8a
LPS (EU/mL) 0.7±0.01a 0.9±0.01b 0.6±0.01a
NEFA: non-esteriﬁed fatty acids; TNF-α: tumor necrosis factor alpha; LPS: lipopolysaccharide; MCP-1:
monocyte chemoattractant protein-1. Data are presented as means±S.E.M. from n = 8 animals/group.
Different superscripted letters indicate statistically signiﬁcant differences (P < 0.05).
doi:10.1371/journal.pone.0149033.t004
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Fig 1. Effect ofω-3 PUFA on glucose and lipid metabolism. HOMA-IR index (A); Plasma insulin (B), and glucose (C) concentrations at different time
intervals after glucose load and respective area under curve (AUC) (upper inserts) and insulin tolerance test (D) are shown. Representative western blots of
insulin-induced Akt phosphorylation (Ser473) (E), and lipid content (F)in skeletal muscle are also reported. The graphic reported in panel 1E represent the
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conditions, SS subpopulation from LD and FD showed an higher State 3 compared to CD-fed
animals. Notably, SS mitochondrial sub-populations of FD exhibited a further increase in State
3 compared to LD group, paralleled by higher levels of CPT activity; no significant difference
was found in CPT activity in the IMF sub-population (Fig 2C).
Proton-leakage from IMF was not influenced by the different diets (data not shown), and
comparable basal proton-leak values were measured in SS mitochondria obtained from differ-
ent groups (Fig 2D). With regard to fatty-acid-induced proton leak (measured using physiolog-
ical amounts of palmitate), SS mitochondria of LD rats had the lowest proton leak among the
three groups, and FD rats had the highest proton leak among the three groups analysed (Fig
2E). To compare the kinetic curves, oxygen consumption was also reported at a membrane
potential of 160 mV (the highest membrane potential common to all obtained curves). FD-fed
rats consumed more oxygen than LD- or CD-fed rats to maintain a given membrane potential
(Fig 2E, upper insert). In IMF and SS mitochondrial populations, a significantly lower aconi-
tase activity (Fig 2F) and a higher H2O2 yield (Fig 2G) clearly demonstrated that LD feeding
enhanced the levels of pro-oxidant markers in muscle mitochondria compared to FD and CD
regimens (P<0.01).
In addition, we analyzed the expression of the FGF21, PGC1α and PGC1β genes. FGF21
mRNA levels in LD rats were significantly increased compared with CD and FD rats (Fig 2H).
PGC1-α and PGC1-βmRNA levels significantly increased in FD compared to the other groups
and significantly decreased in LD compared to the other groups (Fig 2I–2L).
The protective effects produced by FD feeding on skeletal muscle redox status were clearly
indicated by the significant increased GSH/GSSG ratios respect to LD (Fig 3A upper insert).
Moreover, the pro-oxidant effect produced by LD intake was demonstrated by a significantly
lower GSH content (Fig 3A) and higher PC level in skeletal muscle (Fig 3B) and in serum (Fig
3B upper insert); these parameters were unchanged between FD rats and controls (Fig 3A and
3B), confirming the beneficial effect of fish oil in the high fat diet.
The negligible differences in Nrf2 protein translocation into cell nuclei together with com-
parable GST and NQO1 activities measured in skeletal muscle (Fig 3C) indicate that the Nrf2
pathway is not involved in both different high fat diet-mediated modulation of redox status.
Increased TNFα, BiP/GRP78 and eIF2-α levels (Fig 3D–3F) were detected in the skeletal
muscle of LD, whereas the levels in FD rats were similar to CD rats. Finally, pAMPK protein
content was significantly lower in the skeletal muscle of LD-fed rats than in those of the other
experimental groups (Fig 3G). LD-diet exhibited an inhibitory effect on AMPK activity, as
indicated by a concomitant decline of ACC phosphorylation (Fig 3H), which is an indicator of
AMPK activity [41].
Discussion
The main finding of this study is that the intake of ω-3 PUFAs enriched diet, at high percent-
age, reduces fat accumulation in skeletal muscle and decreases metabolic/mitochondrial effi-
ciency, attenuating insulin resistance, ER- and oxidative-stress, compared to an isocaloric high
fat diet rich in SFAs. Moreover, SS mitochondria were identified as the main target of diet-
induced alterations in function and efficiency. The effects exerted by ω-3 PUFAs intake have
been associated to mitochondrial uncoupling and AMPK/ACC, rather than to Nrf2 pathway
activation in skeletal muscle.
densitometric analysis of protein band obtained in three separate experiments. Haematoxylin-eosin sections of glycogen (G upper panels), ADRP
expression (G lower panels) are shown. PAS positive material was stained magenta at a magnification of 20x. Values are expressed as means±SEM from
n = 8 animals/group. Different superscripted letters indicate statistically significant differences (P<0.05).
doi:10.1371/journal.pone.0149033.g001
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Fig 2. Effect ofω-3 PUFA onmitochondrial functions and energy efficiency. IMF and SSmitochondrial respiration in the presence of succinate (A) or
palmitoyl-carnitine (B) as substrates were determined. CPT activity (C); basal (D) or palmitate-induced (E) proton leakage in SS mitochondria and respiration
rates at 160 mV (the highest membrane potential common to all the curves) (upper insert); aconitase activity (F); H2O2 yield (G), relative mRNA expression of
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Here, LD-feeding was associated with high metabolic efficiency, weight gain, body lipid lev-
els, and also with metabolic alterations, such as dyslipidemia, and insulin resistance, accompa-
nied by an increase in low grade inflammation compared to a standard diet. As reported,
despite comparable ME intake between LD and FD groups, the substitution in lard-based diet
with ω-3 PUFA in high fat fed animals showed a reduction in metabolic efficiency, body weight
and body lipid levels, accordingly with a correction of dyslipidemia and insulin resistance.
These data are consistent with previous findings, indicating a reversal of insulin resistance by
ω-3 PUFA intake [42,43]. The effects on body weight and lipids, we observed in FD-fed rats,
can be explained, at least in part, by an increase in energy expenditure/O2 consumption and
reduced energy efficiency. Moreover, the decreased RQ index observed in LD and FD-fed ani-
mals, which reflects the ratio of carbohydrate to fatty acid oxidation, demonstrates that these
animals used a higher amount of fatty acids, as a fuel source, compared to controls. These data
indicate that FD intake improves the ability to utilise fat, as a metabolic fuel, which suggests
that the large part of the higher energy intake was dissipated through increased metabolic activ-
ity in these animals.
An interesting finding is that high-fish oil diet despite to any effect on glycaemia in confront
of LD, it is able to attenuate the development of insulin resistance, preventing the alteration of
glucose tolerance related to an impairment of insulin signalling due to fat over nutrition. The
improvement in insulin sensitivity may be, at least in part, a consequence of the anti-inflamma-
tory effect of ω-3 PUFAs in this nutritional model. Our previous study showed that high-fish
oil diet attenuated the development of systemic and tissue inflammation [23] and decreased
hepatic lipid accumulation through improved mitochondrial fatty acid utilization supported by
mitochondrial uncoupling [24].
Here, HOMA index and oral glucose and insulin tolerance tests showed that high-fish oil
diet attenuated alteration of glucose homeostasis compared to an isocaloric lard-based diet,
indicating that fat present in the diet (lard or fish oil) can differently modify insulin sensitivity.
Consistently, at skeletal muscle level, FD also attenuated tissue insulin resistance, modulat-
ing insulin signalling, restoring protein kinase B (PKB/Akt) phosphorylation and decreased
lipid accumulation, increasing ADRP levels, involved in the proper TG storage [44], and
AMPK activation. All these metabolic effects of fish oil fat diet are strengthened by the suppres-
sion of inflammatory process, evidenced by reduced serum levels of TNFα, MCP-1 and LPS,
and of ER stress at skeletal muscle level, where GRP78 expression and eif2α activation were
down-regulated.
The effects of ω-3 PUFA overload on the prevention of weight gain excess and the develop-
ment of insulin resistance may be mediated by adiponectin and leptin, two adipokines that reg-
ulate glucose and lipid metabolism, through AMPK activation [11,12]. Our results
demonstrate decreased serum leptin levels in FD, consistently with fat mass reduction, com-
pared to LD rats, and restored serum adiponectin levels to those of CD rats, suggesting a key
role of fish oil in the reduction of the development of insulin resistance in an animal model of
fat overnutrition. The reduced adiponectin values found in LD rats were consistent with those
reported by Kalupahana et al. [45]. It is well known the lipid sensor activity of AMPK, an
important metabolic regulator [46]. Notably, the activation of AMPK exhibits multiple protec-
tive effects, including a reduction in inflammation, oxidative stress and insulin resistance [46].
Recently it has been reported that AMPK activation protects against lipid-induced disorders
FGF21 (H), PGC1α (I), PGC1β (L) are also shown. Values are expressed as means±SEM from n = 8 animals/group. Different superscripted letters indicate
statistically significant differences (P<0.05).
doi:10.1371/journal.pone.0149033.g002
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Fig 3. Effect ofω-3 PUFA on oxidative- and ER-stress and AMPK activation. Total thiols (A) and GSH/GSSG ratio (upper insert); protein carbonyl levels
in skeletal muscle (B) and in serum (upper insert). Cytoplasmic GST and NQO1 activities and Nrf2 levels in nucleus (C). Representative immunoblots of
TNFα (D) and BiP/GRP78 (E) p-eIF2-α (F), pAMPK (G) and pACC (H) are shown. Densitometric analysis of protein bands are reported: after normalisation
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[6,7] by reducing ER stress. Previous findings by Jelenik et al. [22] showed that ω-3 PUFAs
intake induced AMPK activation in liver, reverting insulin resistance and steatosis in mice.
Here, we found that FD, in a different way by LD, modulated AMPK/ACC pathway restor-
ing adiponectin and fatty acid metabolism in skeletal muscle. Skeletal muscle is the primary tis-
sue involved in the regulation of glucose metabolism, energy expenditure and lipid utilization
and it is inherently linked to the development of whole-body insulin resistance [47]. The recog-
nized link between insulin resistance and mitochondrial dysfunction [3,48] prompted us to
evaluate the effect of dietary fat regimens on mitochondrial oxidative capacity, energy effi-
ciency, and oxidative stress in both SS and IMF mitochondrial populations. Indeed, SS mito-
chondria provide energy for membrane-related processes, such as substrate oxidation and
insulin action, whereas IMF mitochondria support muscle contraction [49]. In addition, SS
mitochondria may be more susceptible to damage by ectopic lipid deposition, because lipid
content decreases exponentially from immediately below the sarcolemma toward the central
region of the muscle fibre [50]. Because of their proximity to the sarcolemmal membrane, SS
mitochondria can more easily interfere with key proteins involved in the insulin-signalling cas-
cade [50], anyway a pivotal role in insulin-mediated glucose transporter trafficking has been
shown also for t-tubules structure [51]. Interestingly, we demonstrate that both fat diets mainly
affects SS, rather than IMF mitochondria, indicating that the observed mitochondrial alter-
ations may contribute to the pathogenesis of insulin resistance. In particular, no difference was
observed in IMF mitochondria uncoupling, while SS subpopulation demonstrated an increased
uncoupling in FD fed rats.
Association between diet-induced ectopic fat storage in skeletal muscle and mitochondrial
dysfunction is well known [3,48]. Accordingly, LD-rat skeletal muscle mitochondria exhibited
reduced respiratory capacity, as indicated by the decrease in succinate State 3 oxygen consump-
tion, and increased oxidative stress, even when the ability to utilize fat as a metabolic fuel was
elevated. The increased mitochondrial fatty acid oxidation could be a result of an diet-induced
increase of FFA uptake and/or enhanced CPT activity which would further increase the entry
of long-chain FFA into the mitochondria. However, as such increased lipid oxidation is likely
not sufficient to handle the greater FFAs load, resulting in the ectopic triglyceride storage in
skeletal muscle. Moreover, a further mechanism contributing to fat accumulation can be the
increase in mitochondrial efficiency, as shown by the decrease in the induced proton leak in
LD rats. Therefore, a higher mitochondrial efficiency, suggestive of a reduced amount of sub-
strate to be burned to obtain ATP, together with an increase in NEFA serum levels could
account for the triglyceride accumulation in skeletal muscle.
In our experimental conditions, mitochondrial dysfunction in LD rats was related to an
increase in FGF21 gene expression in skeletal muscle, which follows a stress response [52].
Increased mitochondrial oxidative stress parameters were found in LD rats as showed by
hydrogen peroxide yield, aconitase activity, protein carbonyls amount and GSH/GSSG ratio.
This effect can be attributable to the concomitant increase in fatty acid oxidation rate, resulting
in NADH and FADH2 generation and thus electron delivery to the respiratory chain, and to
respiratory chain impairment (as indicated by the decrease in succinate State 3 oxygen con-
sumption, which would partially block electron flow within the respiratory chain). Further, the
decreased proton leak can contribute to excessive ROS formation [53] in LD rats. In fact, one
of the postulated roles of uncoupling is known to be the maintenance of mitochondrial mem-
brane potential below the critical threshold for ROS production [54].
the levels are expressed as the density ratio of target to control (tubulin, lamin or total protein). Values are expressed as means±SEM from n = 8 animals/
group. Different superscripted letters indicate statistically significant differences (P<0.05).
doi:10.1371/journal.pone.0149033.g003
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The improvement of respiratory capacity, fatty acid oxidation, CPT activity and the
decreased mitochondrial efficiency, exhibited by the FD rats, may be interpreted as the result
of converging protective mechanisms against insulin resistance. In addition, the significant
alteration of all the considered oxidative stress markers mirrors the differential ability of ω-3
PUFA- and SFA-based diets to trigger oxidative stress in skeletal muscle [43]. In addition, in
FD-fed animals the increased respiratory capacity is associated with the increase in gene
expression levels of FGF-21, PGC-1α and PGC-1β, involved not only in the regulation of mito-
chondrial activities and biogenesis [55–58], but also to the development of insulin resistance in
skeletal muscle [59]. The increase in mitochondrial biogenesis was supported by changes in
mitochondrial protein mass calculated by two different approaches, namely 1) by measuring
the activity of a mitochondrial marker enzyme citrate synthase in skeletal muscle homogenates
and in isolated SS and IMF mitochondria and 2) by evaluating the mitochondrial yield (i.e.,
milligrams isolated protein per gram starting wet tissue) in each mitochondrial subpopulation.
Independent of the methodology applied, we found that the mitochondrial mass was signifi-
cantly increased in both SS and IMF compartments in FD rats and significantly reduced in LD
rats (see data in S1 Text). Therefore, ω-3 PUFAs, in addition to their positive effect on mito-
chondrial respiration, also act on the level of mitochondrial gene expression in skeletal muscle
cells: the increase in PGC-1α should play a role in the recovery of mitochondrial respiration,
promoting both oxidative phosphorylation-linked and uncoupling-linked respiration in differ-
entiated myotubes oxidative capacity in skeletal muscle cells [60–62].
Conversely, the negligible alteration of Nrf2-pathway, which plays a key role in cellular pro-
tection against oxidative stress, is consistent with evidence demonstrating that transient and
low-levels of ROS are needed for Nrf2-antioxidant responsive element pathway activation [63].
In conclusion, our data strengthened the capability of high dietary PUFA intake to reduce
fat mass and insulin resistance associated to fat overnutrition, modulating energy efficiency. In
particular, at skeletal muscle level, ω-3 PUFAs enriched diet promotes inefficient metabolism,
generating heat instead of ATP, increases lipid oxidation, activating the pathway AMPK/ACC,
and reduces ROS generation in mitochondria. Therefore, modulating mitochondrial function
and efficiency in the skeletal muscle, they lessen pro-inflammatory, pro-oxidant signs and insu-
lin resistance also in condition of nutritionally-induced obesity.
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